SECsense Logo

Edessa Biotech, Inc. 8-K Filing: Key Updates on February 14, 2025

$EDSA
Form 8-K
Filed on: 2025-02-14
Source
Edessa Biotech, Inc. 8-K Filing: Key Updates on February 14, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Filing Type and Date:
  • Form: 8-K
  • Filing Date: February 14, 2025
  1. Company Information:
  • Company Name: Edessa Biotech, Inc.
  • CIK (Central Index Key): 0001540159
  • SEC File Number: 001-37619
  • Address: 100 Spy Court, Markham, ON L3R 5H6, Canada
  • Phone Number: 800-960-289
  1. Stock Information:
  • Ticker Symbol: EDSA
  • Exchange: NASDAQ
  • Type of Shares: Common Shares
  1. Reporting Period:
  • The reporting period for the information is specific to February 14, 2025, which indicates this filing contains timely information relevant to that single date.
  1. Currency and Measurement Units:
  • Currency: USD (United States Dollar)
  • Measurement Units: Shares and USD per Share

This information indicates that the 8-K filing is a current report that Edessa Biotech, Inc. submitted to the SEC to disclose significant events or corporate changes. The details provided suggest a focus on share-related information, which could imply the announcement of a new issuance, corporate action, or other significant updates related to equity.